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Melkersson-Rosenthal syndrome (MRS) consists of 
persistent or recurrent orofacial edema, relapsing facial palsy 
and fissured tongue. The complete triad of symptoms is 
uncommon, varying from 8 to 25%. The presentation of only 
one symptom is more common. The most frequent complaint 
is facial edema and enlargement of the lips. We describe a 
case of a 17-year-old Brazilian girl with limited edema of the 
lower lip and fissured tongue due to MRS. Her complaints 
had started two years before. She referred previous clinical 
treatments without success. We proposed intralesional 
injection of triamcinolone at 20 mg every 15 days associated 
with oral clofazimine at 50 mg/day for three months. The lip 
became normal after four triamcinolone injections. Recent 
studies have considered MRS a granulomatous disease, and 
possibly the initial presentation of Crohn’s disease in orofacial 
area of some patients. MRS patients, therefore, should be 
screened and monitored for gastrointestinal symptoms. 
Corticosteroid treatment seems to be effective in reducing lip 
enlargement. We discus the clinical features of this disease, 
the treatment, and the importance of corticosteroid therapy 
in cases of MRS-related facial palsy.
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INTRODUCTION
Swelling of the lips, plicated tongue (lingua plicata), 
and recurring facial paralysis characterize the Melkersson-
Rosenthal syndrome (MRS). The classical triad occurs in 
8% to 25% of cases.1 Most of these cases present with few 
symptoms; the usual finding is granulomatous cheilitis 
(Miesher’s cheilitis) which is the most common form.1
Miesher’s cheilitis is characterized by recurring and 
painless localized lip swelling, and is part of the orofacial 
granulomatosis group (OFG).1 The chronic and recurring 
nature of the inflammation leads to fibrosis and permanent 
lip swelling, which makes treatment difficult, and relapses 
frequent. Histologically it is characterized by non-caseating 
granulomatous inflammation.2,3
Recent studies have suggested an association be-
tween the OFG and Crohn’s disease (CD), based on the 
histological similarity between both conditions and the 
occurrence of MRS manifestations as the initial presentation 
of CD.3,4 Conceivably these findings could be different 
presentations of the same entity.5
The aim of this study is to present the case report of 
a patient with granulomatous cheilitis and plicated tongue 
that had an excellent response to treatment with intrale-
sional triamcinolone. We report the clinical progression, 
treatment options and the possible association between 
MRS and CD.
CASE REPORT
A female Caucasian patient aged 17 years presented 
progressive and persistent swelling of the lips during the 
last two years.
The physical examination showed localized swelling 
in the lower lip (Figure 1) and plicated tongue. Histology 
of the affected lip revealed inflammation consisting of 
non-caseating granulomas. An assessment of the digestive 
tract was within normal limits.
Treatment involved intralesional injection of a cor-
ticosteroid (triamcinolone 20mg/ml, 1ml each 15 days du-
ring 60 days) and clofazimine (50mg/day) during 90 days. 
The lip swelling reduced markedly after the first month 
of treatment. Full resolution occurred after 4 sessions of 
corticosteroid use.
DISCUSSION
Orofacial granulomatosis may precede or follow 
the diagnosis of CD by years. It could be seen as an oral 
mucosal manifestation of inflammation presenting in the 
digestive tract.5 Patients with MRS should be warned about 
the possible development of CD, and should undergo an 
assessment of the digestive tract.4,5
The accepted treatment of orofacial granulomatosis 
with lip swelling is the intralesional injection of corticoste-
roids, combined or not with oral clofazimine.3.6 Follow-
up shows that local treatment alone is less effective than 
combined treatment with local corticosteroids and systemic 
anti-inflammatory drugs.6
CONCLUSION
The Melkerson-Rosenthal syndrome has been des-
cribed as a granulomatous disease, which has implications 
for its treatment. Follow-up of granulomatous cheilitis has 
shown that intralesional triamcinolone combined with oral 
clofazimine is an effective treatment.
Figure 1. Granulomatous cheilitis with localized swelling in the lower 
left lip.
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